Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia

J Neurosci. 2007 Oct 17;27(42):11424-30. doi: 10.1523/JNEUROSCI.2847-07.2007.

Abstract

Evidence supports a dysregulation of subcortical dopamine (DA) system function as a common etiology of psychosis; however, the factors responsible for this aberrant DA system responsivity have not been delineated. Here, we demonstrate in an animal model of schizophrenia that a pathologically enhanced drive from the ventral hippocampus (vHipp) can result in aberrant dopamine neuron signaling. Adult rats in which development was disrupted by prenatal methylazoxymethanol acetate (MAM) administration display a significantly greater number of spontaneously firing ventral tegmental DA neurons. This appears to be a consequence of excessive hippocampal activity because, in MAM-treated rats, vHipp inactivation completely reversed the elevated DA neuron population activity and also normalized the augmented amphetamine-induced locomotor behavior. These data provide a direct link between hippocampal dysfunction and the hyper-responsivity of the DA system that is believed to underlie the augmented response to amphetamine in animal models and psychosis in schizophrenia patients.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology*
  • Animals
  • Disease Models, Animal
  • Dopamine / physiology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Hippocampus / physiopathology*
  • Male
  • Methylazoxymethanol Acetate / analogs & derivatives
  • Methylazoxymethanol Acetate / toxicity
  • Rats
  • Rats, Sprague-Dawley
  • Schizophrenia / chemically induced
  • Schizophrenia / metabolism*
  • Schizophrenia / physiopathology*

Substances

  • Methylazoxymethanol Acetate
  • methylazoxymethanol
  • Dopamine